- Home
- RNA vs WTM Comparison
RNA vs WTM Comparison
Compare RNA & WTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- WTM
- Stock Information
- Founded
- RNA 2012
- WTM 1980
- Country
- RNA United States
- WTM Bermuda
- Employees
- RNA N/A
- WTM N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- WTM Property-Casualty Insurers
- Sector
- RNA Health Care
- WTM Finance
- Exchange
- RNA Nasdaq
- WTM Nasdaq
- Market Cap
- RNA 4.0B
- WTM 4.6B
- IPO Year
- RNA 2020
- WTM N/A
- Fundamental
- Price
- RNA $46.92
- WTM $1,795.87
- Analyst Decision
- RNA Strong Buy
- WTM
- Analyst Count
- RNA 15
- WTM 0
- Target Price
- RNA $68.40
- WTM N/A
- AVG Volume (30 Days)
- RNA 3.7M
- WTM 21.6K
- Earning Date
- RNA 08-07-2025
- WTM 08-07-2025
- Dividend Yield
- RNA N/A
- WTM 0.05%
- EPS Growth
- RNA N/A
- WTM N/A
- EPS
- RNA N/A
- WTM 79.93
- Revenue
- RNA $10,729,000.00
- WTM $2,578,600,000.00
- Revenue This Year
- RNA N/A
- WTM N/A
- Revenue Next Year
- RNA $196.18
- WTM N/A
- P/E Ratio
- RNA N/A
- WTM $23.39
- Revenue Growth
- RNA 1.23
- WTM 12.16
- 52 Week Low
- RNA $21.51
- WTM $1,666.22
- 52 Week High
- RNA $56.00
- WTM $2,023.00
- Technical
- Relative Strength Index (RSI)
- RNA 71.22
- WTM 60.01
- Support Level
- RNA $45.06
- WTM $1,744.00
- Resistance Level
- RNA $47.24
- WTM $1,880.11
- Average True Range (ATR)
- RNA 2.58
- WTM 28.78
- MACD
- RNA 0.50
- WTM 8.41
- Stochastic Oscillator
- RNA 81.95
- WTM 73.72
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About WTM White Mountains Insurance Group Ltd.
White Mountains Insurance Group Ltd is engaged in the business of making opportunistic and value-oriented acquisitions of businesses and assets in the insurance, financial services, and related sectors, operating these businesses and assets through its subsidiaries and, if and when attractive exit valuations become available, disposing of these businesses and assets. The company conducts its business in five areas: property and casualty insurance and reinsurance, municipal bond reinsurance, capital solutions for asset and wealth management firms, property and casualty insurance distribution, and other operations.